Kamalesh Poornachary

Title: Kamalesh Poornachary: Innovator in Neuropharmacology

Introduction

Kamalesh Poornachary is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of neuropharmacology, particularly through his innovative research and patenting of compounds that target specific receptors in the brain.

Latest Patents

Kamalesh Poornachary holds a patent for "GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH." This patent discloses compounds that selectively inhibit GluN2B-containing N-methyl-D-aspartic acid receptors (NM/DARs). The compounds are designed to selectively target GluN2B over other subunits such as GluN2A, GluN2C, and GluN2D. Notably, these compounds exhibit enhanced potency at a more acidic pH compared to physiological pH. The patent also includes pharmaceutical formulations containing these compounds and methods for treating various conditions, disorders, and diseases, including stroke, cerebral ischemia, and neurodegenerative diseases.

Career Highlights

Throughout his career, Kamalesh Poornachary has worked with esteemed institutions such as Emory University and Neurop, Inc. His work has focused on developing innovative solutions for complex neurological conditions, showcasing his commitment to advancing medical science.

Collaborations

Kamalesh has collaborated with prominent figures in the field, including Dennis C. Liotta and Stephen F. Traynelis. These collaborations have further enriched his research and contributed to the development of effective therapeutic strategies.

Conclusion

Kamalesh Poornachary's contributions to neuropharmacology through his patent and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in the treatment of neurological disorders.